US6951271005
US6951271005
Pacira BioSciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.45B EUR | 1.01B EUR | 888.4M EUR | 1.06B EUR |
Enterprise Value | 1.61B EUR | 1.22B EUR | 1.16B EUR | 1.32B EUR |
Valuation Multiples | ||||
Trailing P/E | 103.74x | 69.02x | 172.91x | 478.89x |
Forward P/E | 10.5x | -- | -- | -- |
Price to Sales | 1.94x | 1.35x | 1.21x | 1.91x |
Price to Book | 2.15x | 1.5x | 1.36x | 1.54x |
EV/Revenue | 2.16x | 1.63x | 1.57x | 2.37x |
EV/EBITDA | 13x | 10.49x | 10.38x | 15.75x |
Price to FCF (P/FCF) | 14.74x | 5.63x | 6.69x | 9.7x |
EV/FCF | 16.39x | 6.78x | 8.71x | 12.06x |
FCF Yield | 6.79% | 17.77% | 14.94% | 10.31% |